| __timestamp | Gilead Sciences, Inc. | argenx SE |
|---|---|---|
| Wednesday, January 1, 2014 | 2983000000 | 4241601.57 |
| Thursday, January 1, 2015 | 3426000000 | 5392385.38 |
| Friday, January 1, 2016 | 3398000000 | 7370036.73 |
| Sunday, January 1, 2017 | 3878000000 | 14970357 |
| Monday, January 1, 2018 | 4056000000 | 31413266 |
| Tuesday, January 1, 2019 | 4381000000 | 72279461 |
| Wednesday, January 1, 2020 | 5151000000 | 183907682 |
| Friday, January 1, 2021 | 5246000000 | 307644000 |
| Saturday, January 1, 2022 | 5673000000 | 472132000 |
| Sunday, January 1, 2023 | 6090000000 | 709539000 |
| Monday, January 1, 2024 | 6091000000 |
In pursuit of knowledge
In the ever-evolving world of biotechnology, understanding the financial dynamics of industry leaders is crucial. Gilead Sciences, Inc. and argenx SE, two prominent players, have shown contrasting trends in their Selling, General, and Administrative (SG&A) expenses over the past decade. From 2014 to 2023, Gilead's SG&A expenses surged by over 100%, peaking at approximately $6 billion in 2023. This reflects their aggressive expansion and strategic investments. In contrast, argenx SE, a rising star, witnessed a staggering 16,600% increase, albeit from a much smaller base, reaching around $709 million in 2023. This growth underscores argenx's rapid scaling and market penetration. As these companies navigate the competitive landscape, their SG&A strategies offer valuable insights into their operational priorities and future trajectories.
Selling, General, and Administrative Costs: Gilead Sciences, Inc. vs Neurocrine Biosciences, Inc.
Who Optimizes SG&A Costs Better? Gilead Sciences, Inc. or Intra-Cellular Therapies, Inc.
Breaking Down SG&A Expenses: Gilead Sciences, Inc. vs Axsome Therapeutics, Inc.
Cost Management Insights: SG&A Expenses for Gilead Sciences, Inc. and Opthea Limited
Operational Costs Compared: SG&A Analysis of Gilead Sciences, Inc. and Cytokinetics, Incorporated
Selling, General, and Administrative Costs: Gilead Sciences, Inc. vs Xenon Pharmaceuticals Inc.
Cost Management Insights: SG&A Expenses for Gilead Sciences, Inc. and ImmunityBio, Inc.
Breaking Down SG&A Expenses: argenx SE vs Walgreens Boots Alliance, Inc.
Breaking Down SG&A Expenses: argenx SE vs Madrigal Pharmaceuticals, Inc.
Operational Costs Compared: SG&A Analysis of argenx SE and Viking Therapeutics, Inc.
argenx SE or TG Therapeutics, Inc.: Who Manages SG&A Costs Better?